Compare Stocks: TCMD, INSP, AXGN, and LMAT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AXGN AxoGen	$35.24 +1.8%	$44.45	$16.65 ▼ $52.91	$1.89B	1.17	1.15 million shs	782,531 shs
INSP Inspire Medical Systems	$70.10 +1.9%	$66.47	$38.91 ▼ $147.03	$2.03B	0.73	1.06 million shs	656,128 shs
LMAT LeMaitre Vascular	$82.31 +1.8%	$80.92	$78.22 ▼ $118.01	$1.88B	0.48	277,246 shs	248,746 shs
TCMD Tactile Systems Technology	$22.73 +0.9%	$22.77	$14.46 ▼ $37.77	$514.84M	0.82	307,540 shs	165,215 shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AXGN AxoGen	0.00%	-4.18%	-21.73%	-12.31%	+108.68%
INSP Inspire Medical Systems	0.00%	-0.26%	-10.58%	+28.80%	-11.93%
LMAT LeMaitre Vascular	0.00%	+0.16%	+2.47%	-20.52%	-6.67%
TCMD Tactile Systems Technology	0.00%	+0.36%	+1.44%	-20.68%	+54.99%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AXGN AxoGen	$35.24 +1.8%	$44.45	$16.65 ▼ $52.91	$1.89B	1.17	1.15 million shs	782,531 shs
INSP Inspire Medical Systems	$70.10 +1.9%	$66.47	$38.91 ▼ $147.03	$2.03B	0.73	1.06 million shs	656,128 shs
LMAT LeMaitre Vascular	$82.31 +1.8%	$80.92	$78.22 ▼ $118.01	$1.88B	0.48	277,246 shs	248,746 shs
TCMD Tactile Systems Technology	$22.73 +0.9%	$22.77	$14.46 ▼ $37.77	$514.84M	0.82	307,540 shs	165,215 shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AXGN AxoGen	0.00%	-4.18%	-21.73%	-12.31%	+108.68%
INSP Inspire Medical Systems	0.00%	-0.26%	-10.58%	+28.80%	-11.93%
LMAT LeMaitre Vascular	0.00%	+0.16%	+2.47%	-20.52%	-6.67%
TCMD Tactile Systems Technology	0.00%	+0.36%	+1.44%	-20.68%	+54.99%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AXGN AxoGen	2.80	Moderate Buy	$51.73	46.79% Upside
INSP Inspire Medical Systems	2.05	Hold	$68.82	-1.83% Downside
LMAT LeMaitre Vascular	2.44	Hold	$110.60	34.37% Upside
TCMD Tactile Systems Technology	2.67	Moderate Buy	$37.60	65.42% Upside

Current Analyst Ratings Breakdown

Latest TCMD, INSP, AXGN, and LMAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/14/2026	INSP Inspire Medical Systems	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Hold	$62.00 ➝ $78.00
10/13/2026	TCMD Tactile Systems Technology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C) ➝ Hold (C+)
10/13/2026	INSP Inspire Medical Systems	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$75.00
10/12/2026	AXGN AxoGen	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$52.00
10/12/2026	TCMD Tactile Systems Technology	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$39.00 ➝ $35.00
10/8/2026	LMAT LeMaitre Vascular	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B-)
10/6/2026	INSP Inspire Medical Systems	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Underweight	$65.00
10/6/2026	AXGN AxoGen	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Overweight	$55.00
10/6/2026	AXGN AxoGen	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong-Buy
10/6/2026	INSP Inspire Medical Systems	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Strong Sell
10/5/2026	AXGN AxoGen	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy

(Data available from 10/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AXGN AxoGen	$225.21M	8.41	N/A	N/A	$2.79 per share	12.63
INSP Inspire Medical Systems	$911.98M	2.22	$2.92 per share	24.02	$26.88 per share	2.61
LMAT LeMaitre Vascular	$262.43M	7.17	$2.96 per share	27.85	$17.35 per share	4.74
TCMD Tactile Systems Technology	$329.52M	1.56	$1.16 per share	19.55	$9.80 per share	2.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AXGN AxoGen	-$15.70M	-$0.68	N/A	391.56	N/A	-13.36%	-8.90%	-6.47%	10/28/2026 (Estimated)
INSP Inspire Medical Systems	$145.42M	$4.62	15.17	45.52	5.20	15.03%	8.64%	7.45%	11/2/2026 (Estimated)
LMAT LeMaitre Vascular	$57.73M	$2.85	28.88	25.88	2.33	25.02%	15.63%	10.06%	11/4/2026 (Estimated)
TCMD Tactile Systems Technology	$19.09M	$1.08	21.05	16.84	N/A	7.10%	11.49%	9.17%	11/2/2026 (Estimated)

Latest TCMD, INSP, AXGN, and LMAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	LMAT LeMaitre Vascular	$0.6860	N/A	N/A	N/A	$67.39 million	N/A
11/2/2026	Q3 2026	INSP Inspire Medical Systems	$0.0870	N/A	N/A	N/A	$204.31 million	N/A
11/2/2026	Q3 2026	TCMD Tactile Systems Technology	$0.30	N/A	N/A	N/A	$91.99 million	N/A
10/28/2026	Q3 2026	AXGN AxoGen	$0.1340	N/A	N/A	N/A	$73.18 million	N/A
8/10/2026	Q2 2026	TCMD Tactile Systems Technology	$0.1350	$0.34	+$0.2050	$0.34	$85.52 million	$85.70 million
8/4/2026	Q2 2026	LMAT LeMaitre Vascular	$0.8070	$0.74	-$0.0670	$0.74	$71.47 million	$70.38 million
8/3/2026	Q2 2026	INSP Inspire Medical Systems	-$0.2359	$0.14	+$0.3759	$0.01	$194.72 million	$200.58 million
7/29/2026	Q2 2026	AXGN AxoGen	$0.1214	$0.12	-$0.0014	-$0.03	$67.10 million	$69.73 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AXGN AxoGen	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
LMAT LeMaitre Vascular	$1.00	1.21%	+16.05%	35.09%	14 Years
TCMD Tactile Systems Technology	N/A	N/A	N/A	N/A	N/A

Latest TCMD, INSP, AXGN, and LMAT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/28/2026	LMAT LeMaitre Vascular	quarterly	$0.25	1.21%	8/20/2026	8/20/2026	9/3/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AXGN AxoGen	0.07	6.60	5.04
INSP Inspire Medical Systems	N/A	8.55	6.16
LMAT LeMaitre Vascular	0.40	16.31	13.96
TCMD Tactile Systems Technology	N/A	4.12	3.68

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AXGN AxoGen	80.29%
INSP Inspire Medical Systems	94.91%
LMAT LeMaitre Vascular	84.64%
TCMD Tactile Systems Technology	83.43%

Insider Ownership

Company	Insider Ownership
AXGN AxoGen	2.44%
INSP Inspire Medical Systems	2.20%
LMAT LeMaitre Vascular	7.40%
TCMD Tactile Systems Technology	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AXGN AxoGen	622	53.76 million	52.45 million	Optionable
INSP Inspire Medical Systems	1,333	28.91 million	28.27 million	Optionable
LMAT LeMaitre Vascular	655	22.87 million	21.18 million	Optionable
TCMD Tactile Systems Technology	1,086	22.65 million	22.18 million	Optionable

TCMD, INSP, AXGN, and LMAT Headlines

Recent News About These Companies

Tactile Medical to Release Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

3 hours ago | globenewswire.com

Tactile Systems Technology (NASDAQ:TCMD) Stock Gets Downgrade from Wall Street Zen

October 19 at 1:24 AM | americanbankingnews.com

Tactile Systems Technology (NASDAQ:TCMD) Cut to Buy at Wall Street Zen

October 17 at 4:06 AM | marketbeat.com

BTIG cuts target for Tactile Systems Technology stock to USD 35.00

October 15, 2026 | ad-hoc-news.deA

Tactile Systems Technology (NASDAQ:TCMD) Stock Gets Price Target Trim from BTIG Research

October 12, 2026 | marketbeat.com

Tactile Systems Technology (NASDAQ:TCMD) vs. Zynex (NASDAQ:ZYXI) Head to Head Contrast

October 8, 2026 | americanbankingnews.com

MarketBeat gives Tactile Systems Technology stock a Moderate Buy consensus

October 7, 2026 | ad-hoc-news.deA

Tactile Systems Technology, Inc. (NASDAQ:TCMD) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

October 5, 2026 | marketbeat.com

52,370 Shares of Tactile Systems Technology, Inc. $TCMD Purchased by Bank of America Corp DE

October 2, 2026 | marketbeat.com

Tactile Systems Technology (NASDAQ:TCMD) Raised to "Strong-Buy" at Wall Street Zen

September 26, 2026 | marketbeat.com

Tactile Systems Technology stock falls 1.19 percent on Q2 update

September 23, 2026 | ad-hoc-news.deA

Tactile Systems Technology, Inc. Q2 2026 Earnings Call Summary

August 12, 2026 | finance.yahoo.com

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Tactile Systems Technology (TCMD)

August 12, 2026 | theglobeandmail.com

Tactile Systems Technology: Q2 Earnings Snapshot

August 11, 2026 | chron.com

Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results

August 11, 2026 | markets.businessinsider.com

Tactile Systems Technology, Inc. (TCMD) Q2 2026 Earnings Call Transcript

August 10, 2026 | seekingalpha.com

Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates

August 10, 2026 | zacks.com

Tactile Systems Technology (TCMD) Releases Q2 2026 Earnings: Revenue and EPS Beat Expectations

August 10, 2026 | quiverquant.comQ

Tactile Systems Technology : TCMD

July 21, 2026 | 247wallst.com

Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026

July 21, 2026 | globenewswire.com

Tactile Systems: Clean Balance Sheet, But A Possible Value Trap

July 14, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TCMD, INSP, AXGN, and LMAT Company Descriptions

AxoGen NASDAQ:AXGN

$35.24 +0.62 (+1.79%)

Closing price 04:00 PM Eastern

Extended Trading

$34.91 -0.33 (-0.94%)

As of 07:40 PM Eastern

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Inspire Medical Systems NYSE:INSP

$70.10 +1.31 (+1.91%)

Closing price 03:59 PM Eastern

Extended Trading

$70.16 +0.05 (+0.07%)

As of 07:47 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

LeMaitre Vascular NASDAQ:LMAT

$82.31 +1.49 (+1.84%)

Closing price 04:00 PM Eastern

Extended Trading

$82.30 -0.01 (-0.01%)

As of 07:30 PM Eastern

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Tactile Systems Technology NASDAQ:TCMD

$22.73 +0.21 (+0.93%)

Closing price 04:00 PM Eastern

Extended Trading

$22.74 +0.00 (+0.02%)

As of 07:30 PM Eastern

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TCMD, INSP, AXGN, and LMAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TCMD, INSP, AXGN, and LMAT Earnings

Compare Dividends

Latest TCMD, INSP, AXGN, and LMAT Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TCMD, INSP, AXGN, and LMAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TCMD, INSP, AXGN, and LMAT Company Descriptions

AxoGen NASDAQ:AXGN

Inspire Medical Systems NYSE:INSP

LeMaitre Vascular NASDAQ:LMAT

Tactile Systems Technology NASDAQ:TCMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools